A Study of APL-10456-Vaccine
Clinical trial NCT07399132 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07399132
- Sponsor
- Apollo Therapeutics Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-16
- Primary completion
- 2027-05-18
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.